AR-12286 in Combination With Latanoprost

NCT01302249 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension

Interventions

DRUG: Latanoprost 0.005%
DRUG: AR-12286 Ophthalmic Solution 0.5%
DRUG: Timolol maleate ophthalmic solution 0.5%

Sponsor

Aerie Pharmaceuticals